share_log

HC Wainwright & Co. Reiterates Buy on Aurinia Pharmaceuticals, Maintains $15 Price Target

HC Wainwright & Co. Reiterates Buy on Aurinia Pharmaceuticals, Maintains $15 Price Target

HC Wainwright & Co.重申买入Aurinia Pharmicals,维持15美元的目标股价
Benzinga ·  2023/09/22 06:20

HC Wainwright & Co. analyst Ed Arce reiterates Aurinia Pharmaceuticals (NASDAQ:AUPH) with a Buy and maintains $15 price target.

HC Wainwright&Co.分析师埃德·阿尔斯重申金色制药(纳斯达克:AUPH)买入,并维持15美元的目标价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发